Emergent Biosolutions (EBS)
NYSE:EBS
Holding EBS?
Track your performance easily

Emergent Biosolutions (EBS) Financial Statements

1,217 Followers

Emergent Biosolutions Financial Overview

Emergent Biosolutions's market cap is currently ―. The company's EPS TTM is $-4.098; its P/E ratio is -2.87; Emergent Biosolutions is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 293.80M$ 254.70M$ 300.40M$ 269.90M$ 270.50M
Gross Profit$ 171.20M$ -41.40M$ 155.80M$ 84.80M$ 93.70M
EBIT$ 142.40M$ -269.80M$ 36.40M$ -32.80M$ -246.20M
EBITDA$ 162.10M$ -236.30M$ 71.20M$ -3.20M$ -212.50M
Net Income Common Stockholders$ 114.80M$ -283.10M$ 9.00M$ -49.50M$ -263.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 149.90M$ 69.70M$ 78.50M$ 111.70M$ 87.80M
Total Assets$ 1.48B$ 1.51B$ 1.80B$ 1.82B$ 1.89B
Total Debt$ 662.60M$ 862.20M$ 905.90M$ 860.20M$ 861.80M
Net Debt$ 512.70M$ 792.50M$ 827.40M$ 748.50M$ 774.00M
Total Liabilities$ 969.40M$ 1.13B$ 1.14B$ 1.17B$ 1.20B
Stockholders Equity$ 508.40M$ 386.30M$ 663.90M$ 649.30M$ 697.20M
Cash Flow-
Free Cash Flow$ 155.50M$ 42.90M$ -73.40M$ 20.70M$ 47.40M
Operating Cash Flow$ 153.70M$ 47.50M$ -62.60M$ 32.10M$ 60.00M
Investing Cash Flow$ 112.00M$ -4.60M$ -10.80M$ -11.40M$ -18.90M
Financing Cash Flow$ -180.30M$ -50.90M$ 40.70M$ 4.70M$ -43.00M
Currency in USD

Emergent Biosolutions Earnings and Revenue History

Emergent Biosolutions Debt to Assets

Emergent Biosolutions Cash Flow

Emergent Biosolutions Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis